AXA Framlington Health R Income GBP
GB0005753719
AXA Framlington Health R Income GBP/ GB0005753719 /
NAV01/10/2024 |
Diferencia+0.3100 |
Tipo de beneficio |
Enfoque de la inversión |
Sociedad de fondos |
32.5400GBP |
+0.96% |
paying dividend |
Equity
Worldwide
|
AXA IM (UK) ▶ |
Estrategia de inversión
The aim of this Fund is to provide long-term capital growth over a period of 5 years or more.
The Fund invests in shares of listed healthcare companies including producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies, which the Manager believes will provide above-average returns. The Fund invests in companies of any size which can be based anywhere in the world albeit the Fund tends to be biased towards the US, as this is where the majority of healthcare related companies are based. The Manager selects shares based upon analysis of a company"s financial status, quality of its management, expected profitability and prospects for growth. The Manager has full discretion to select investments for the Fund in line with the above investment policy and in doing so may take into consideration the MSCI World Healthcare index. The MSCI World Healthcare index is designed to measure the performance of large and mid-cap segments across a number of developed markets as selected by the index provider. This index best represents the types of companies in which the Fund predominantly invests.
Objetivo de inversión
The aim of this Fund is to provide long-term capital growth over a period of 5 years or more.
Datos maestros
Tipo de beneficio: |
paying dividend |
Categoría de fondos: |
Equity |
Región: |
Worldwide |
Sucursal: |
Sector Health / Pharma |
Punto de referencia: |
MSCI World Healthcare Total Return Net |
Inicio del año fiscal: |
01/11 |
Última distribución: |
01/11/2017 |
Banco depositario: |
HSBC Bank Plc |
País de origen: |
United Kingdom |
Permiso de distribución: |
United Kingdom |
Gestor de fondo: |
Dani SAURYMPER,Linden Thomson |
Volumen de fondo: |
- |
Fecha de fundación: |
27/02/1987 |
Enfoque de la inversión: |
- |
Condiciones
Recargo de emisión: |
0.00% |
Max. Comisión de administración: |
1.50% |
Inversión mínima: |
1,000.00 GBP |
Deposit fees: |
0.70% |
Cargo por amortización: |
0.00% |
Prospecto simplificado: |
Descargar (Versión para imprimir) |
Sociedad de fondos
Fondos de empresa: |
AXA IM (UK) |
Dirección: |
7 Newgate Street, EC1A 7NX, London |
País: |
United Kingdom |
Internet: |
institutional.axa-im.co.uk/
|
Países
United States of America |
|
65.45% |
Denmark |
|
8.87% |
Switzerland |
|
7.89% |
United Kingdom |
|
5.26% |
France |
|
3.44% |
Germany |
|
2.55% |
Italy |
|
2.09% |
Ireland |
|
1.83% |
Netherlands |
|
1.35% |
Cash |
|
1.27% |
Sucursales
Pharma/Biotechnology |
|
49.40% |
Healthcare services |
|
22.70% |
Healthcare appliances |
|
21.25% |
Parma, wholesale |
|
4.19% |
Cash |
|
1.27% |
Gesundheitswesen/ Informationstechnologie |
|
1.19% |